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We describe a case of a 61-year-old Korean man who was diagnosed with renal cell carcinoma 
that was discovered on abdominopelvic computed tomography obtained after the patient com-
plained of back pain. A radical nephrectomy was performed, and the surgical specimen showed 
a relatively well-circumscribed and yellowish lobulated hard mass. Microscopically, the tumor 
showed sheets and nests of hypercellular pleomorphic cells with thick fibrous septation, frequent 
mitoses, and areas of adrenal cortical-like tissue. Immunohistochemical staining revealed that the 
tumor cells were positive for inhibin-α, vimentin, synaptophysin, and melan A. It also revealed that 
the tumor cells were negative for pan-cytokeratin, epithelial membrane antigen, paired box 8, 
α-methylacyl-coenzyme A racemase, CD10, cytokeratin 7, carbonic anhydrase 9, c-Kit, renal cell 
carcinoma, transcription factor E3, human melanoma black 45, desmin, smooth muscle actin, 
S-100, chromogranin A, CD34, anaplastic lymphoma kinase, and integrase interactor 1. Based on 
these histopathological and immunohistochemical findings, we diagnosed the tumor as intrarenal 
adrenocortical carcinoma arising in an adrenal rest. Several cases of intrarenal adrenocortical 
carcinoma have been reported, although they are very rare. Due to its poor prognosis and common 
recurrence or metastasis, clinicians and pathologists must be aware of this entity.
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▒ CASE STUDY ▒
Adrenocortical carcinoma is a rare and heterogeneous malig-
nancy with a poor prognosis, the pathogenesis of which is not 
yet completely understood. Patients present with hormone excess 
or local mass effect.1 An adrenal rest (ectopic adrenal tissue) can 
occur anywhere along the gonadal descent. This tissue usually 
has no clinical significance, but it may become hyperplastic or 
malignant in patients with primary or secondary adrenal pathol-
ogy.2 Most adrenal rest tumors are functional and diagnosed 
preoperatively. However, the less frequent nonfunctional adrenal 
rest tumors are discovered accidentally or postoperatively.3 We 
described a patient with a nonfunctioning intrarenal adrenocor-
tical carcinoma that arose from an adrenal rest.
CASE REPORT
This study was approved by the Institutional Review Board 
of Severance Hospital with a waiver of informed consent (IRB 
No. 4-2017-1044).
A 61-year-old man was evaluated for back pain that had persisted 
for 10 days. Abdominopelvic computed tomography (APCT) and 
magnetic resonance imaging were performed at a local clinic and 
revealed a 13-cm mass in his right kidney. The mass was causing 
an ureteropelvic junction obstruction that broadly contacted 
the second and third duodenal portions, psoas muscle, and inferior 
vena cava. All radiologic findings were consistent with renal cell 
carcinoma with multiple lung metastases. The patient was hos-
pitalized at our institution, and the APCT was repeated and 
provided the same diagnosis (Fig. 1A). 
The patient underwent radical nephrectomy without adrenal-
ectomy. The right kidney weighed 1,135 g and measured 17 × 
12 × 6 cm. The tumor had a smooth and bulging external surface. 
Cross sections revealed a well-circumscribed and yellowish lobu-
lated hard mass (Fig. 1B) measuring 14 × 12 × 8 cm, present in 
the mid pole of the right kidney. The mass showed extensive 
necrosis (60%) and hemorrhage (30%).
Microscopically, the tumor had multilobulated nests divided 
by thick fibrous septations (Fig. 2A). The tumor was comprised 
of compact polygonal cells with distinct cell borders and granular 
cytoplasm. Sinusoidal vascular ingrowth was less distinct. Nuclei 
were round or ovoid, hyperchromatic with central prominent 
nucleoli, and contained frequent mitoses (40/50 high-power 
fields) (Fig. 2B) without raisinoid nuclei or perinuclear haloes. 
Some areas containing adrenal cortical-like tissues were identified 
(Fig. 2C). Necrosis and vascular invasion were also present. These 
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results suggested against the diagnosis of renal cell carcinoma.
Immunohistochemical staining results are presented in Table 
1 and Fig. 3. The results were consistent with adrenocortical 
carcinoma and excluded the possibility of renal cell carcinoma 
and specific variants of the kidney tumor. 
DISCUSSION
Ectopic or accessory adrenal cells are often found postnatally 
along the path of gonadal descent because the adrenocortical 
primordium develops in close proximity to the urogenital ridge of 
the emerging gonad and migrates alongside the gonad.4 Typically, 
these cells disappear within a few years of birth, and sometimes 
these cells linger without any event. 
Ye et al.4 reported seven cases of intrarenal adrenal tissue and 
two cases of renal-adrenal fusion. Except for one case identified 
within the kidney mid pole, all intrarenal lesions were found in 
the superior portion of the kidney. Our case reports a malignant 
tumor arising from the ectopic adrenal rest in the mid pole of 
the kidney. In all nine reported cases of Ye et al.,4 the intrarenal 
Fig. 1. Imaging and gross findings of adrenocortical carcinoma. (A) Abdominopelvic computed tomography reveals a 13 cm heterogeneous 
mass in the right kidney. (B) Bisected kidney specimen showing a lobulated hard mass with necrosis and hemorrhage.
Fig. 2. Histologic findings of adrenocortical carcinoma. (A) Sheets and nests of hypercellular tumor cells with thick fibrous septation. (B) Pleo-
morphic cells with frequent mitoses. (C) Areas of adrenal cortical-like tissue.
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Table 1. Immunostaining results of adrenocortical carcinoma
Antigen Tumor cell
Pan-cytokeratin Negative
EMA Negative
Inhibin-α Positive
Vimentin Positive
Melan A Focal positive 
Synaptophysin Positive
Paired box 88 Negative
Calretinin Negative
α-Methylacyl-coenzyme A racemase Negative
CD10 Negative
Cytokeratin 7 Negative
Carbonic anhydrase 9 Negative
C-kit Negative
Renal cell carcinoma Negative
Transcription factor E3 Negative
Human melanoma black 45 Negative
Desmin Negative
Smooth muscle actin Negative
S-100 Negative
Chromogranin A Negative
CD 34 Negative
Anaplastic lymphoma kinase Negative
Integrase interactor 1 No loss
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adrenal tissues were composed of only adrenal cortical tissue with 
no adrenal medullary tissue present. There is a recent review of 
the literature about adrenocortical carcinoma arising in an adrenal 
rest. Reported malignant tumors arising from an ectopic adrenal 
rest are predominantly adrenocortical carcinomas of the retro-
peritoneum, gonad, liver, kidney, spinal cord, and pelvis.5 Intra-
renal adrenocortical carcinomas have been previously identified 
in the hilum3 and in the mid pole of the kidney as in our case. 
Adrenocortical carcinomas that involve the gonads show relatively 
high rates of mortality.6-8
The microscopic features that favor the diagnosis of renal cell 
carcinoma over adrenocortical carcinoma are the presence of glands, 
particularly if they contain red blood cells, and abundant cyto-
plasmic glycogen. However, neither is pathognomonic and were 
present in the case. Among the nine histological parameters of the 
Weiss scoring system for histologic diagnosis of adrenocortical 
carcinoma (high nuclear grades [Fuhrman nuclear grades III and 
IV], mitotic rate > 5/50 high-power fields, atypical mitotic figures, 
clear tumor cell cytoplasm [less than 25% tumor cells], diffuse 
architecture [greater than 33% of tumor], necrosis, venous inva-
sion, sinusoidal invasion, and capsular invasion), the present case 
met seven parameters, excluding sinusoidal invasion and capsular 
invasion. After the diagnosis of renal cell carcinoma was excluded 
by morphology and negative cytokeratin expression, we exam-
ined additional immunohistochemical stains to differentiate epi-
thelioid angiomyolipoma, adrenocortical carcinoma, glomus 
tumor, or related mesenchymal tumors. Finally, we defined the 
tumor as adrenocortical carcinoma (pT2NxcM1).
Currently, radical surgery is the only curative approach, and 
it is recommended for all patients with resectable adrenocortical 
carcinoma tumors, including those patients with recurrent disease. 
There is no consensus concerning adjuvant therapy.9 However, 
recent studies have reported that adjuvant mitotane may prolong 
recurrence-free survival in patients with radically resected adre-
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Fig. 3. Immunohistochemical staining results of adrenocortical carcinoma. The tumor cells were positive for inhibin-α (A), vimentin (B), synap-
tophysin (C), and melan A (D) and negative for epithelial membrane antigen (E), paired box 8 (F), and pan-cytokeratin (G).
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nocortical carcinoma.10,11
Our patient was treated with radical nephrectomy and adjuvant 
chemotherapy (VAP; vincristine, doxorubicin, and prednisolone) 
with mitotane. He has been healthy with no evidence of recur-
rence or metastasis for 3 months after the original diagnosis. 
Recent studies have reported the prevalence of adrenocortical 
carcinoma in Korea to be 2%–5%. In our institution, five cases 
of adrenocortical carcinoma were reported from 2000 to 2018. 
Among them, this is the only and first reported case of intrarenal 
adrenocortical carcinoma. We reported a rare case of intrarenal 
adrenocortical carcinoma arising from an ectopic adrenal rest as 
a mimicker of renal cell carcinoma in the kidney. Although the 
incidence of malignancy arising in an adrenal rest is low, clinicians 
and pathologists must be aware of the possibility because of its 
poor prognosis and common recurrence and metastasis.
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